News

Mindera Health™ announces publication of randomized, prospectiveclinical utility study demonstrating improved psoriasis patient outcomes

Using Mind.Px™ test results, altered physician prescribing behavior leads to faster,more effective patient outcomes VISTA – May 13, 2025 – Mindera Health, a leader in precision medicine for dermatological conditions, today announced positive results from the completion of a randomized, prospective clinical trial (MATCH) aimed at demonstrating the clinical utility of Mind.Px™, the first realization

Mindera Health™ announces publication of randomized, prospectiveclinical utility study demonstrating improved psoriasis patient outcomes Read More »